Pharmacists and patients benefit from faster, smarter approvals.
A daily roadblock in pharmacy care
If you’ve ever worked in a pharmacy or tried to fill a prescription that required prior authorization (PA), you know the frustration. For years, PA has stood as one of healthcare’s biggest hurdles by delaying treatment, exhausting pharmacy staff, and leaving patients in limbo. Often times, colleagues spend entire afternoons faxing forms and making follow-up calls, all in hopes of getting a medication approved.
But what if there was a way to clear this roadblock? That’s where artificial intelligence (AI) is beginning to make a difference.
How AI is streamlining the process
Imagine a tool that does what used to take days or even weeks, automatically, and in minutes. AI-powered automation now integrates with electronic health records (EHRs) and insurance platforms to:
- Scan patient documentation instantly
- Identify clinical criteria needed for approval
- Submit and track requests in real time
The result? Fewer errors, more complete submissions, and far less time spent on paperwork. In many cases, approvals that once took days are now processed in minutes. For patients, that means fewer interruptions and a better chance of staying on therapy. For pharmacists, it’s a chance to focus on what matters most: counseling patients, checking for interactions, and supporting medication adherence.
Beyond efficiency: Quality and connection
AI isn’t just about speed. By automating repetitive tasks, it gives clinical teams the bandwidth to strengthen their relationships with patients.
- More time for patient conversations: Instead of juggling forms, pharmacists can counsel patients on side effects, lifestyle changes, and safe use.
- Improved outcomes: Faster approvals mean fewer missed doses and less chance a patient gives up on needed treatment.
- Fewer administrative errors: With AI catching missing info before submission, denials drop and appeals become less necessary.
Navigating the challenges
Of course, technology is not a cure all. It’s important to remain vigilant about:
- Transparency: Patients and clinicians deserve to know how AI decisions are made.
- Payer alignment: Insurers, pharmacies, and prescribers need to agree on rules and processes.
- Oversight: AI should support (not replace) clinical judgment. Pharmacists must review any automated decision that could impact patient safety.
As the American Medical Association points out, unregulated or poorly designed AI can sometimes increase denials if payers use it to restrict access rather than improve care (American Medical Association, 2025). Oversight, standards, and ongoing pharmacist involvement are non-negotiable.
Where do we go from here?
AI in prior authorization isn’t about removing the human touch. It’s about returning it. Let’s push for solutions that speed up approvals while honoring the expertise of pharmacists and the needs of patients.
